Relapsed/Refractory Hematological Malignancies
4 clinical trials · Condition
◉ Watch Relapsed/Refractory Hematological Malignancies
| Record | Firm | Date |
|---|---|---|
| Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies (NCT05528887) | The Affiliated People's Hospital of Ningbo University | 2021-09-16 |
| A Study of TQB3473 Tablets in Subjects With Relapsed or Refractory Hematological Malignancies (NCT04412577) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-10-12 |
Track Relapsed/Refractory Hematological Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.